Advertisement

Mitochondrial DNA Depletion due to Mutations in the TK2 Gene

Chapter

Abstract

Thymidine kinase 2 (TK2), encoded by the TK2 gene, is an essential component of the mitochondrial nucleotide salvage pathway responsible for the maintenance of mitochondrial deoxyribonucleotide pools. TK2 mutations lead to mitochondrial DNA (mtDNA) depletion syndrome. Although the myopathic type of mtDNA depletion syndrome seemed to be the main associated clinical phenotype, other clinical features such as central nervous system and liver involvement have been described, expanding the clinical spectrum of clinical spectrum of this condition. Cellular compensatory mechanisms leading to normal activities of the mitochondrial respiratory chain and even reversion of mtDNA depletion have been observed. Mouse models of this disease have revealed altered neuronal bioenergetics and neurodegeneration with high relevance for the mechanisms of neurological involvement in mtDNA depletion syndromes.

Keywords

Mitochondrial DNA depletion TK2 gene Thymidine kinase 2 

References

  1. 1.
    Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S (1991) mtDNA depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492–501PubMedGoogle Scholar
  2. 2.
    Suomalainen A, Isohanni P Mitochondrial DNA depletion syndromes–many genes, common mechanisms, Neuromuscul. Disord 20:429–437Google Scholar
  3. 3.
    Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344PubMedCrossRefGoogle Scholar
  4. 4.
    Bogenhagen D, Clayton DA (1977) Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle. Cell 11:719–727PubMedCrossRefGoogle Scholar
  5. 5.
    Rampazzo C, Fabris S, Franzolin E, Crovatto K, Frangini M, Bianchi V (2007) Mitochondrial thymidine kinase and the enzymatic network regulating thymidine triphosphate pools in cultured human cells. J Biol Chem 282:34758–34769PubMedCrossRefGoogle Scholar
  6. 6.
    Alberio S, Mineri R, Tiranti V, Zeviani M (2007) Depletion of mtDNA: syndromes and genes. Mitochondrion 7:6–12PubMedCrossRefGoogle Scholar
  7. 7.
    Mancuso M, Filosto M, Bonilla E, Hirano M, Shanske S, Vu TH, DiMauro S (2003) Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene. Arch Neurol 60:1007–1009PubMedCrossRefGoogle Scholar
  8. 8.
    Pons R, Andreetta F, Wang CH, Vu TH, Bonilla E, DiMauro S, De Vivo DC (1996) Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 15:153–158PubMedCrossRefGoogle Scholar
  9. 9.
    Mancuso M, Salviati L, Sacconi S, Otaegui D, Camano P, Marina A, Bacman S, Moraes CT, Carlo JR, Garcia M, Garcia-Alvarez M, Monzon L, Naini AB, Hirano M, Bonilla E, Taratuto AL, DiMauro S, Vu TH (2002) Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology 59:1197–1202PubMedCrossRefGoogle Scholar
  10. 10.
    Wang L, Limongelli A, Vila MR, Carrara F, Zeviani M, Eriksson S (2005) Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. Mol Genet Metab 84:75–82PubMedCrossRefGoogle Scholar
  11. 11.
    Oskoui M, Davidzon G, Pascual J, Erazo R, Gurgel-Giannetti J, Krishna S, Bonilla E, De Vivo DC, Shanske S, DiMauro S (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122–1126PubMedCrossRefGoogle Scholar
  12. 12.
    Galbiati S, Bordoni A, Papadimitriou D, Toscano A, Rodolico C, Katsarou E, Sciacco M, Garufi A, Prelle A, Aguennouz M, Bonsignore M, Crimi M, Martinuzzi A, Bresolin N, Papadimitriou A, Comi GP (2006) New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 34:177–185PubMedCrossRefGoogle Scholar
  13. 13.
    Saada A, Shaag A, Elpeleg O (2003) mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. Mol Genet Metab 79:1–5PubMedCrossRefGoogle Scholar
  14. 14.
    Frangini M, Rampazzo C, Franzolin E, Lara MC, Vila MR, Marti R, Bianchi V (2009) Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2-mutated fibroblasts. FEBS J 276:1104–1113PubMedCrossRefGoogle Scholar
  15. 15.
    Collins J, Bove KE, Dimmock D, Morehart P, Wong LJ, Wong B (2009) Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations. Neuromuscul Disord 19:784–787PubMedCrossRefGoogle Scholar
  16. 16.
    Vila MR, Villarroya J, Garcia-Arumi E, Castellote A, Meseguer A, Hirano M, Roig M (2008) Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency. J Neurol Sci 267:137–141PubMedCrossRefGoogle Scholar
  17. 17.
    Vila MR, Segovia-Silvestre T, Gamez J, Marina A, Naini AB, Meseguer A, Lombes A, Bonilla E, DiMauro S, Hirano M, Andreu AL (2003) Reversion of mtDNA depletion in a patient with TK2 deficiency. Neurology 60:1203–1205PubMedCrossRefGoogle Scholar
  18. 18.
    Vu TH, Tanji K, Valsamis H, DiMauro S, Bonilla E (1998) Mitochondrial DNA depletion in a patient with long survival. Neurology 51:1190–1193PubMedCrossRefGoogle Scholar
  19. 19.
    Barthelemy C, Ogier de Baulny H, Diaz J, Cheval MA, Frachon P, Romero N, Goutieres F, Fardeau M, Lombes A (2001) Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. Ann Neurol 49:607–617PubMedCrossRefGoogle Scholar
  20. 20.
    Leshinsky-Silver E, Michelson M, Cohen S, Ginsberg M, Sadeh M, Barash V, Lerman-Sagie T, Lev D (2008) A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion. Eur J Paediatr Neurol 12:309–313PubMedCrossRefGoogle Scholar
  21. 21.
    Lesko N, Naess K, Wibom R, Solaroli N, Nennesmo I, von Dobeln U, Karlsson A, Larsson NG (2010) Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. Neuromuscul Disord 20:198–203PubMedCrossRefGoogle Scholar
  22. 22.
    Gotz A, Isohanni P, Pihko H, Paetau A, Herva R, Saarenpaa-Heikkila O, Valanne L, Marjavaara, S, Suomalainen A (2008) Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain 131:2841–2850PubMedCrossRefGoogle Scholar
  23. 23.
    Zhang S, Li FY, Bass HN, Pursley A, Schmitt ES, Brown BL, Brundage EK, Mardach R, Wong LJ (2010) Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion. Mol Genet Metab 99:53–57PubMedCrossRefGoogle Scholar
  24. 24.
    Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086PubMedCrossRefGoogle Scholar
  25. 25.
    Marti R, Nascimento A, Colomer J, Lara MC, Lopez-Gallardo E, Ruiz-Pesini E, Montoya J, Andreu AL, Briones P, Pineda M (2010) Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene. Pediatr Res 68:151–154PubMedCrossRefGoogle Scholar
  26. 26.
    Tyynismaa H, Sun R, Ahola-Erkkila S, Almusa H, Poyhonen R, Korpela M, Honkaniemi J, Isohanni P, Paetau A, Wang L, Suomalainen A (2012) Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet 21:66–75PubMedCrossRefGoogle Scholar
  27. 27.
    Zhou X, Solaroli N, Bjerke M, Stewart JB, Rozell B, Johansson M, Karlsson A (2008) Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Genet 17:2329–2335PubMedCrossRefGoogle Scholar
  28. 28.
    Bartesaghi S, Betts-Henderson J, Cain K, Dinsdale D, Zhou X, Karlsson A, Salomoni P, Nicotera P (2010) Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration. Hum Mol Genet 19:1669–1677PubMedCrossRefGoogle Scholar
  29. 29.
    Akman HO, Dorado B, Lopez LC, Garcia-Cazorla A, Vila MR, Tanabe LM, Dauer WT, Bonilla E, Tanji K, Hirano M (2008) Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum Mol Genet 17:2433–2440PubMedCrossRefGoogle Scholar
  30. 30.
    Nevo Y, Soffer D, Kutai M, Zelnik N, Saada A, Jossiphov J, Messer G, Shaag A, Shahar E, Harel S, Elpeleg O (2002) Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion. J Child Neurol 17:499–504PubMedCrossRefGoogle Scholar
  31. 31.
    Villarroya J, Lara MC, Dorado B, Garrido M, Garcia-Arumi E, Meseguer A, Hirano M, Vila MR (2011) Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity. Biochem Biophys Res Commun 407:333–338PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.BMC Medical GeneticsLondonUK
  2. 2.Department of Molecular and Human GeneticsBaylor College of Medicine and Texas Children’s Hospital, Clinical Care CenterHoustonUSA

Personalised recommendations